Aleksandra Stjepanovic

Aleksandra Stjepanovic is a highly experienced professional in clinical development, currently serving as Senior Director and Head of Late-Stage Clinical Development at Almirall since October 2022. In this role, Stjepanovic leads the Late-stage Clinical Development Group focused on drug development in immunology and dermatology, overseeing global clinical strategy from phase 2b to regulatory approval. Previously, Stjepanovic was Senior Clinical Research Director at Sanofi Genzyme, where responsibilities included developing global strategies for biologics such as Dupixent® and leading large cross-functional teams. Stjepanovic has considerable experience across various therapeutic areas, including diabetes and neuropsychiatry, and has held significant clinical roles at Servier and MDS Pharma Services. Early medical training included positions at the Military Medical Academy in Serbia and University Hospital Belgrade.